| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | Australia | 3 | |
| #4 | Canada | 3 | |
| #5 | China | 3 | |
| #6 | Taiwan | 3 | |
| #7 | WIPO (World Intellectual Property Organization) | 3 | |
| #8 | Hungary | 2 | |
| #9 | Israel | 2 | |
| #10 | Mexico | 2 | |
| #11 | Brazil | 1 | |
| #12 | Hong Kong | 1 | |
| #13 | Republic of Korea | 1 | |
| #14 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chang Wei-Wei | 28 |
| #2 | Sawyer Kenneth I | 24 |
| #3 | Sawyer Kenneth | 6 |
| #4 | Chang Wei Wei | 2 |
| #5 | Wei-Wei Chang | 2 |
| #6 | Kenneth I Sawyer | 1 |
| #7 | Kenneth Sawyer | 1 |
| #8 | Zhang Weiwei | 1 |
| #9 | Sawyer Kenneth I I | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA3042213A1 | Treatment of symptoms related to neurodegenerative disorders through pharmacological dermal activation of cranial nerves | |
| CA2956919A1 | Method for treating radiotherapy-and chemotherapy-associated cognitive or emotional impairment with cannabinoids | |
| CA2909490A1 | Cranial delivery of pharmaceuticals | |
| TW201416076A | Compositions and treatment for eye diseases and disorders | |
| NZ704247A | Compositions and treatment for eye diseases and disorders |